Evidence map›Paper›PMID 34762773›Full record

ArticleInternational journal of experimental pathology2021

Correlation between aryl hydrocarbon receptor and IL-17

Soheila Fattahi, Monireh Karimi, Mahdi Ghatreh-Samani, Fatemeh Taheri, Hedayatollah Shirzad, Faramarz Mohammad Alibeigi, Maryam Anjomshoa, Nader Bagheri

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of experimental pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Correlation between aryl hydrocarbon receptor and IL-17International journal of experimental pathology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Soheila FattahiCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Monireh KarimiCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Mahdi Ghatreh-SamaniCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Fatemeh TaheriDepartment of Pathology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Hedayatollah ShirzadCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Faramarz Mohammad AlibeigiDepartment of Urology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Maryam AnjomshoaDepartment of Anatomical Sciences, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Nader BagheriCellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.ORCID 0000-0001-5196-5513
Shahrekord University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer (BC) is one of the most prevalent cancers around the world and, if not treated well, has high morbidity and mortality. Many studies have indicated that there may be various roles for the aryl hydrocarbon receptor (AHR) in the immune system. The aim of this study was to determine the frequency of Foxp3

Indexed as

AgedAged, 80 and overCell DifferentiationFemaleForkhead Transcription FactorsHumansInterleukin-17MaleMiddle AgedReceptors, Aryl HydrocarbonT-Lymphocytes, RegulatoryUrinary Bladder NeoplasmsForkhead Transcription FactorsFOXP3 protein, humanInterleukin-17Receptors, Aryl Hydrocarbonaryl hydrocarbon receptorbladder cancerFoxp3+ regulatory TT helper 17

Identifiers

PMID34762773
PMCPMC8626624
OpenAlexW3213455470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.